Antimicrobial Agents and Chemotherapy · 2010 · 255 citations · 12 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceDiagnostic MicrobiologyMedical MicrobiologyAntibacterial ResistanceAntibiotic ResistanceAntibiotic Resistance MechanismsBeta-lactam ResistanceCarbapenem ResistanceResistance In Gram-positive BacteriaCarbapenem AntibioticsCarbapenem Resistance MechanismsCarbapenem-hydrolyzing EnzymesCarbapenemase EnzymesExtended-spectrum Beta-lactamase InhibitorsExtended-spectrum Beta-lactamase Producing OrganismsExtended-spectrum Beta-lactamase ProductionExtended-spectrum Beta-lactamase-producing Organisms
Combinations of NXL104 with ceftazidime and aztreonam were tested against carbapenem-resistant members of the Enterobacteriaceae. Ceftazidime-NXL104 was active against strains with the OXA-48 enzyme or with combinations of impermeability and an extended-spectrum β-lactamase (ESBL) or AmpC enzyme and also against most Klebsiella spp. with the KPC enzyme, but metallo-β-lactamase producers were resistant. Aztreonam-NXL104 was active against all carbapenemase producers at 4 and 4 μg/ml, including those with metallo-β-lactamases.
12
Kanimozhi Kumarasamy, Mark A. Toleman, Timothy R. Walsh et al. · The Lancet Infectious Diseases · 2010 · 2.9K citations · Full text
Brandon Kitchel, J. Kamile Rasheed, Jean B. Patel et al. · Antimicrobial Agents and Chemotherapy · 2009 · 530 citations · Full text
Michel Doumith, Matthew J. Ellington, David M. Livermore et al. · Journal of Antimicrobial Chemotherapy · 2009 · 439 citations · Full text
Spread of OXA-48-Encoding Plasmid in Turkey and Beyond
Laurent Poirel, Mesut Yılmaz, Özay Arıkan Akan et al. · Antimicrobial Agents and Chemotherapy · 2010 · 267 citations · Full text